RxDoctor Payments Data

Troy Halteman, PA

Medical · Monroeville, PANPI 1689226573

Payments from drug & device makers

$2,285in general payments, 2019–2025

Across 125 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$413
  • Novartis$265
  • E.r. Squibb & Sons, L.L.C.$176
  • Pfizer$162
  • Bayer$153
  • Boehringer Ingelheim$151
  • plus $966 from 16 others

What the payments were for

  • Food & beverage$2,285100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,285 in reported general payments places this provider in the 80th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$21,530
Medicare patients
153
Services billed
463

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban195$247,045
Repatha SureclickEvolocumab107$99,644
JardianceEmpagliflozin48$73,733
XareltoRivaroxaban52$49,129
EntrestoSacubitril/Valsartan35$40,445
FarxigaDapagliflozin Propanediol34$23,951
BrilintaTicagrelor24$20,107
Icosapent Ethyl14$5,967
VascepaIcosapent Ethyl11$3,835
Rosuvastatin Calcium240$3,116
Atorvastatin Calcium266$2,832
Metoprolol Succinate191$2,739
Ranolazine ErRanolazine22$2,209
Valsartan68$1,715
Flecainide Acetate24$1,549

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$162$247,045195 claims
Boehringer IngelheimJardiance$151$73,73348 claims
Johnson & JohnsonXarelto$49$49,12952 claims
AstraZenecaFarxiga, Brilinta$83$44,05858 claims
NovartisEntresto$265$40,44535 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Monroeville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →